The Priority Review

Policy Brief

Astromech acquires Form Bio in $230 million all-stock deal

The transaction was announced on Nov. 17, 2026 as a stock deal. The acquisition brings Form Bio's intellectual property, selected contracts and assets, and team into Astromech, combining evolutionary modeling with tools for designing genetic medicines.

Primary source

Company press release (PR Newswire), November 17, 2026

Astromech Acquires Form Bio, Bringing Together Evolutionary AI and Genetic Medicine Design Under One Directive

Read the source: Astromech Acquires Form Bio, Bringing Together Evolutionary AI and Genetic Medicine Design Under One Directive prnewswire.com

Machine-summarized from the source above; not independently reported. How we use automation